1	Oncor	NNP	2	nn
2	Inc.	NNP	8	nsubj
3	,	,	2	punct
4	Gaithersburg	NNP	2	appos
5	,	,	4	punct
6	Md.	NNP	4	appos
7	,	,	2	punct
8	said	VBD	0	root
9	it	PRP	10	nsubj
10	received	VBD	8	ccomp
11	approval	NN	10	dobj
12	from	IN	11	prep
13	the	DT	18	det
14	U.S.	NNP	18	nn
15	Food	NNP	18	nn
16	and	CC	15	cc
17	Drug	NNP	15	conj
18	Administration	NNP	12	pobj
19	to	TO	20	aux
20	market	VB	11	infmod
21	a	DT	23	det
22	genetic	JJ	23	amod
23	test	NN	20	dobj
24	that	WDT	26	nsubj
25	will	MD	26	aux
26	assist	VB	23	rcmod
27	in	IN	26	prep
28	diagnosis	NN	27	pobj
29	and	CC	28	cc
30	treatment	NN	28	conj
31	of	IN	28	prep
32	leukemia	NN	31	pobj
33	and	CC	32	cc
34	lymph	NN	35	nn
35	cancer	NN	32	conj
36	.	.	8	punct

1	The	DT	5	det
2	B\/T	NNP	5	nn
3	gene	NN	4	nn
4	rearrangement	NN	5	nn
5	test	NN	8	nsubj
6	is	VBZ	8	cop
7	more	RBR	8	advmod
8	accurate	JJ	32	ccomp
9	than	IN	8	prep
10	existing	VBG	11	amod
11	tests	NNS	9	pobj
12	for	IN	8	prep
13	diagnosing	VBG	12	pcomp
14	the	DT	15	det
15	type	NN	13	dobj
16	of	IN	15	prep
17	cancer	NN	16	pobj
18	,	,	15	punct
19	whether	IN	22	dep
20	it	PRP	22	nsubj
21	has	VBZ	22	aux
22	spread	VBN	15	dep
23	or	CC	22	cc
24	whether	IN	26	dep
25	there	EX	26	expl
26	is	VBZ	22	conj
27	a	DT	28	det
28	recurrence	NN	26	nsubj
29	following	VBG	28	partmod
30	treatment	NN	29	dobj
31	,	,	32	punct
32	said	VBD	0	root
33	Oncor	NNP	34	nn
34	President	NNP	36	nn
35	Stephen	NNP	36	nn
36	Turner	NNP	32	nsubj
37	.	.	32	punct

1	Mr.	NNP	2	nn
2	Turner	NNP	3	nsubj
3	said	VBD	0	root
4	the	DT	5	det
5	test	NN	9	nsubjpass
6	initially	RB	9	advmod
7	will	MD	9	aux
8	be	VB	9	auxpass
9	used	VBN	3	ccomp
10	in	IN	9	prep
11	conjunction	NN	10	pobj
12	with	IN	11	prep
13	biopsies	NNS	12	pobj
14	and	CC	13	cc
15	other	JJ	16	amod
16	tests	NNS	13	conj
17	,	,	9	punct
18	but	CC	9	cc
19	eventually	RB	23	advmod
20	might	MD	23	aux
21	become	VB	23	cop
22	the	DT	23	det
23	benchmark	NN	9	conj
24	for	IN	23	prep
25	tumor	NN	26	nn
26	analysis	NN	24	pobj
27	.	.	3	punct

1	Mr.	NNP	2	nn
2	Turner	NNP	3	nsubj
3	said	VBD	0	root
4	the	DT	5	det
5	test	NN	8	nsubjpass
6	will	MD	8	aux
7	be	VB	8	auxpass
8	shipped	VBN	3	ccomp
9	in	IN	8	prep
10	45	CD	11	num
11	days	NNS	9	pobj
12	to	TO	8	prep
13	hospitals	NNS	12	pobj
14	and	CC	13	cc
15	clinical	JJ	16	amod
16	laboratories	NNS	13	conj
17	.	.	3	punct

1	Dr.	NNP	3	nn
2	Wyndham	NNP	3	nn
3	Wilson	NNP	15	nsubj
4	,	,	3	punct
5	a	DT	8	det
6	cancer	NN	7	nn
7	treatment	NN	8	nn
8	specialist	NN	3	appos
9	at	IN	8	prep
10	the	DT	13	det
11	National	NNP	13	nn
12	Cancer	NNP	13	nn
13	Institute	NNP	9	pobj
14	,	,	3	punct
15	said	VBD	0	root
16	the	DT	17	det
17	test	NN	20	nsubjpass
18	is	VBZ	20	auxpass
19	widely	RB	20	advmod
20	used	VBN	15	ccomp
21	in	IN	20	prep
22	research	NN	23	nn
23	centers	NNS	21	pobj
24	but	CC	20	cc
25	is	VBZ	27	aux
26	n't	RB	27	neg
27	having	VBG	20	conj
28	a	DT	30	det
29	major	JJ	30	amod
30	impact	NN	27	dobj
31	because	IN	36	mark
32	it	PRP	36	nsubj
33	is	VBZ	36	cop
34	only	RB	35	advmod
35	occasionally	RB	36	advmod
36	useful	JJ	27	advcl
37	in	IN	36	prep
38	choosing	VBG	37	pcomp
39	the	DT	42	det
40	most	JJS	41	dep
41	effective	JJ	42	amod
42	treatment	NN	38	dobj
43	.	.	15	punct

1	But	CC	5	cc
2	the	DT	3	det
3	test	NN	5	nsubj
4	may	MD	5	aux
5	prove	VB	24	ccomp
6	to	TO	9	aux
7	be	VB	9	cop
8	more	RBR	9	advmod
9	sensitive	JJ	5	xcomp
10	in	IN	9	prep
11	determining	VBG	10	pcomp
12	whether	IN	16	complm
13	a	DT	14	det
14	tumor	NN	16	nsubj
15	has	VBZ	16	aux
16	spread	VBN	11	ccomp
17	or	CC	16	cc
18	returned	VBN	16	conj
19	following	VBG	16	prep
20	treatment	NN	19	pobj
21	,	,	24	punct
22	Dr.	NNP	23	nn
23	Wilson	NNP	24	nsubj
24	said	VBD	0	root
25	.	.	24	punct

1	``	``	17	punct
2	We	PRP	5	nsubj
3	do	VBP	5	aux
4	n't	RB	5	neg
5	know	VB	17	ccomp
6	yet	RB	5	advmod
7	how	WRB	11	advmod
8	useful	JJ	7	dep
9	it	PRP	11	nsubj
10	's	VBZ	11	aux
11	going	VBG	5	ccomp
12	to	TO	13	aux
13	be	VB	11	xcomp
14	,	,	17	punct
15	''	''	17	punct
16	he	PRP	17	nsubj
17	said	VBD	0	root
18	.	.	17	punct

1	Oncor	NNP	11	nsubj
2	,	,	1	punct
3	a	DT	5	det
4	six-year-old	JJ	5	amod
5	developer	NN	1	appos
6	of	IN	5	prep
7	genetic	JJ	9	amod
8	medical	JJ	9	amod
9	tests	NNS	6	pobj
10	,	,	1	punct
11	projects	VBZ	33	ccomp
12	that	IN	17	complm
13	the	DT	15	det
14	cancer	NN	15	nn
15	test	NN	17	nsubj
16	will	MD	17	aux
17	help	VB	11	ccomp
18	it	PRP	17	dobj
19	to	TO	20	aux
20	post	VB	17	xcomp
21	its	PRP$	23	poss
22	first-ever	JJ	23	amod
23	profit	NN	20	dobj
24	during	IN	20	prep
25	the	DT	27	det
26	first	JJ	27	amod
27	quarter	NN	24	pobj
28	of	IN	27	prep
29	1990	CD	28	pobj
30	,	,	33	punct
31	Mr.	NNP	32	nn
32	Turner	NNP	33	nsubj
33	said	VBD	0	root
34	.	.	33	punct

1	The	DT	2	det
2	company	NN	4	nsubj
3	will	MD	4	aux
4	charge	VB	30	ccomp
5	$	$	4	dobj
6	35	CD	5	num
7	for	IN	4	prep
8	a	DT	9	det
9	test	NN	7	pobj
10	and	CC	4	cc
11	projects	VBZ	4	conj
12	about	IN	13	amod
13	$	$	11	dobj
14	2	CD	13	number
15	million	CD	13	number
16	in	IN	13	prep
17	revenue	NN	16	pobj
18	from	IN	13	prep
19	the	DT	20	det
20	test	NN	18	pobj
21	during	IN	13	prep
22	the	DT	25	det
23	first	JJ	25	amod
24	12	CD	25	num
25	months	NNS	21	pobj
26	of	IN	25	prep
27	marketing	NN	26	pobj
28	,	,	30	punct
29	he	PRP	30	nsubj
30	said	VBD	0	root
31	.	.	30	punct


